Are women meeting cancer-prevention recommendations? Not really.

Share this article:

Most women who reported eating a healthful diet and being physically active to ward off cancer were, in fact, not meeting the minimum recommendations for cancer prevention, according to recent survey findings.

Approximately 200 women responded to a cross-sectional, national, random-digit-dialed telephone survey conducted by Jennifer Irvin Vidrine, PhD, of the Department of Health Disparities Research at The University of Texas MD Anderson Cancer Center in Houston, Texas, and colleagues. The survey addressed women's perceptions regarding diet, exercise, and cancer prevention. As the investigators noted in Journal of Women's Health (2013;22[6]:487-493), most women in the United States do not meet minimum recommendations for fruit/vegetable consumption or physical activity, and the resulting overweight/obesity increases the risks for cancer morbidity and mortality.

The survey responses revealed that only 9.9% of women who reported eating a healthy diet met the minimum daily recommendations of two fruit servings and three vegetable servings set forth by the American Cancer Society (ACS). Similarly, just 39.7% of women who said they engaged in regular physical activity actually met the ACS recommendation of 30 minutes of moderate physical activity 5 days per week.

In analyses adjusted for demographics, low education was associated with reporting regular physical activity to prevent cancer but failing to meet the minimum recommendation. Racial/ethnic minority status was marginally significantly associated with reportedly following a healthful diet to prevent cancer, yet failing to consume sufficient fruits and vegetables.

Vidrine's group advised that public health messages emphasize the importance of specific doses of recommended behaviors and promote awareness of discrepancies between perceptions and actual behavior.
Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Web Exclusives

Screening for Lynch syndrome improves health outcomes at an acceptable cost

Screening families of patients with colorectal cancer for a genetic condition would reduce their risk of developing related cancers, new research has determined.

Outcomes in nonsquamous lung cancer comparable with docetaxel or pemetrexed

The first direct comparison of treating nonsquamous lung cancer with either pemetrexed or docetaxel in addition to cisplatin has shown that the two combinations achieve similar progression-free survival.

JAK inhibitors promising in colorectal cancer

JAK inhibitors have been found to halt tumor growth in colorectal cancer with a certain genetic mutation, according to a new study.